| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,335.7130 | 1,498.3280 | 2,438.5460 | 1,492.5570 | 0 |
| Cost of Revenue
|
-4,158.7120 | -4,424.9660 | -4,115.4690 | -2,709.2510 | 0 |
|
Gross Profit
|
-3,183.9680 | -2,926.6380 | -1,676.9230 | -1,216.6940 | 0 |
| Selling, General and Administrative Expenses
|
-6,490.4230 | -8,178.1370 | -3,489.2020 | -3,868.1910 | -4,411.1870 |
|
Research and Development Expenses
|
-2,664.1470 | -2,361.1190 | -2,267.7390 | -4,022.4580 | -7,763.6430 |
| Depreciation, Amortization and Depletion
|
-- | -- | -- | -- | 0 |
|
Accretion of Asset Retirement Obligation
|
-- | -- | -- | 0 | -2.7260 |
|
Operating Income/Expenses
|
-9,154.5700 | -10,539.2560 | -5,756.9410 | -7,890.6490 | -12,177.5560 |
|
Total Operating Profit/Loss
|
-12,338.5380 | -13,465.8940 | -7,433.8640 | -9,107.3430 | -12,177.5560 |
| Total Net Finance Income/Expense
|
-722.2500 | -691.9300 | -808.9890 | -283.2470 | -53.6030 |
| Net Investment Income
|
1,398.2570 | -31.9020 | -12.7600 | 18.4690 | 28.7520 |
| Irregular Income/Expenses
|
-29.9950 | -- | -- | -- | 0 |
|
Other Income/Expense, Non-Operating
|
174.3760 | 57.5490 | -589.5500 | 3.0780 | 42.9930 |
|
Non-Operating Income/Expenses, Total
|
820.3880 | -666.2830 | -1,411.2990 | -261.7000 | 18.1420 |
|
Pretax Income
|
-11,518.1500 | -14,132.1770 | -8,845.1630 | -9,369.0430 | -12,159.4140 |
|
Net Income from Continuing Operations
|
-11,518.1500 | -14,132.1770 | -8,845.1630 | -9,369.0430 | -12,159.4140 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-11,518.1500 | -14,132.1770 | -8,845.1630 | -9,369.0430 | -12,159.4140 |
|
Net Income after Non-Controlling/Minority Interests
|
-11,518.1500 | -14,132.1770 | -8,845.1630 | -9,369.0430 | -12,159.4140 |
|
Net Income Available to Common Stockholders
|
-11,518.1500 | -14,132.1770 | -8,845.1630 | -9,369.0430 | -12,159.4140 |
|
Diluted Net Income Available to Common Stockholders
|
-11,518.1500 | -14,132.1770 | -8,845.1630 | -9,369.0430 | -12,159.4140 |
| Basic EPS
|
-5.21 | -10.49 | -23.19 | -32.85 | -58.50 |
| Diluted EPS
|
-5.21 | -10.49 | -23.19 | -32.85 | -58.50 |
|
Basic Weighted Average Shares Outstanding
|
2,465.1910 | 1,346.8520 | 381.3500 | 284.8120 | 203.6880 |
|
Diluted Weighted Average Shares Outstanding
|
2,465.1910 | 1,346.8520 | 381.3500 | 284.8120 | 203.6880 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-10,795.9000 | -13,440.2470 | -8,036.1740 | -9,085.7960 | -12,105.8110 |
|
EBITDA
|
-10,545.1840 | -13,187.6340 | -7,639.8590 | -8,492.6270 | -10,981.7080 |
|
Normalized EBITDA
|
-8,678.8930 | -11,125.9810 | -6,081.6550 | -7,547.4680 | -8,955.5030 |
|
Normalized Income
|
-9,651.8590 | -12,070.5240 | -7,286.9590 | -8,423.8840 | -10,133.2090 |
|
Total Unusual Items
|
1,866.2910 | 2,061.6530 | 1,558.2040 | 945.1590 | 2,026.2050 |
12/31/2022 - 6/17/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade